Back to overview

Excellent year for Arseus: turnover increases 10.3% to EUR 391.3 million

News 2 min read

STRUCTURAL EVOLUTION IN ALL DIVISIONS


Waregem
(Belgium), 15 January 2010
– In 2009 the
consolidated turnover of Arseus increased 10.3% to EUR 391.3 million. The organic
growth in 2009 was 4.1%. In the fourth quarter the consolidated turnover
increased 9.9% to EUR 113.9 million. The organic growth was 4.5%.

The evolution
of turnover per division is as follows[1]:

(x EUR 1 million)

Q4 2009

Q4 2008

evolution

organic growth

Fagron

43.1

39.1

10.2%

6.5%

Arseus Dental

46.9

43.0

9.1%

3.8%

Arseus Medical

15.7

14.2

10.6%

-1.1%

Corilus

8.2

7.3

12.3%

9.6%

TOTAL

113.9

103.6

9.9%

4.5%

(x EUR 1 million)

2009

2008

evolution

organic growth

Fagron

150.7

136.9

10.1%

5.6%

Arseus Dental

161.2

144.2

11.8%

3.1%

Arseus Medical

50.6

47.3

7.0%

2.0%

Corilus

28.8

26.2

9.9%

6.3%

TOTAL

391.3

354.6

10.3%

4.1%

Ger van Jeveren, CEO of Arseus: “2009 was in several respects an excellent year for Arseus. Despite the
unfavourable economic circumstances and the cost-saving programme launched at
the start of 2009, all the divisions contributed to the turnover growth of
10.3%, of which no less than 4.1% was organic growth. The emphasis in the first
half of 2009 was on strengthening our management structure, while we used our
healthy financial situation in the second half of 2009 to make some strategic
acquisitions.

We
are confident about the future and confirm our previous outlook that recurring
EBITDA will grow faster than turnover in 2009. Based on our current view and
Arseus’ existing portfolio, we expect to generate turnover growth of between 5%
and 10% in 2010 and a recurring EBITDA that is again expected to grow faster
than turnover.”

[1] Unaudited management
figures.

Please
open the link below for the full press release: